Bixiye
P69-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo barnaamijka: Okt 02, 2023
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1001 - 1010 ee natiijooyinka 3604
Bixiye
P70-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective December 4, 2023
Taariikhda uu dhaqangalayo barnaamijka: Okt 02, 2023
Bixiye
P71-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo barnaamijka: Okt 02, 2023
Bixiye
P72-23 Claims Reimbursement for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo barnaamijka: Okt 02, 2023
Bixiye
2023 October Bulletins
Taariikhda uu dhaqangalayo barnaamijka: Okt 02, 2023
Bixiye
Skyclarys (omaveloxolone) - Commercial
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2025
Bixiye
Ophthalmic Pilocarpine - Commercial
Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2025
Bixiye
Ophthalmic Prostaglandins - Commercial
Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2025
Bixiye
Daybue (trofinetide) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Antiretroviral - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025